HDAC9 and chronic obstructive pulmonary disease: HDAC inhibitors were postulated as possible therapeutic agents in asthma and chronic obstructive pulmonary disease (COPD) [31], methamphetamine addiction [32], heart failure [33,34,35], diabetes [36,37], depression [38], or suppression of aging processes [39].